Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$13.59 USD
-0.85 (-5.89%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $13.58 -0.01 (-0.07%) 7:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 34% (84 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.36 | 1.35 | 9.99 |
Current Quarter Estimate | -0.72 | 2.87 | 60.00 |
Year Ago Quarter Estimate | -0.45 | -5.36 | 52.54 |
Next Quarter Estimate | -0.75 | 7.43 | 61.00 |
Next Year Estimate | -3.28 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -18.87 | 13.30 | 17.08 |
Next Year | -4.13 | 7.80 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 4.21 | 2.22 |
Price/Cash Flow (MRFY) | NA | 15.70 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -178.93% | -100.99% |
Return on Equity (TTM) | -67.09% | -55.59% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.